# Phase 1 Study of HBN-1

> **NCT04094857** · PHASE1 · UNKNOWN · sponsor: **Hibernaid, Inc** · enrollment: 18 (estimated)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** HBN-1

## Key facts

- **NCT ID:** NCT04094857
- **Lead sponsor:** Hibernaid, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-30
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04094857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04094857, "Phase 1 Study of HBN-1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04094857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*